These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Cockcroft-Gault formula is biased by body weight in diabetic patients with renal impairment. Rigalleau V, Lasseur C, Perlemoine C, Barthe N, Raffaitin C, Chauveau P, Combe C, Gin H. Metabolism; 2006 Jan; 55(1):108-12. PubMed ID: 16324928 [Abstract] [Full Text] [Related]
23. Lactate levels in Asian patients with type 2 diabetes mellitus on metformin and its association with dose of metformin and renal function. Lim VC, Sum CF, Chan ES, Yeoh LY, Lee YM, Lim SC. Int J Clin Pract; 2007 Nov; 61(11):1829-33. PubMed ID: 17887995 [Abstract] [Full Text] [Related]
24. Cardiac autonomic neuropathy in diabetes mellitus: prevalence, risk factors and utility of corrected QT interval in the ECG for its diagnosis. Pappachan JM, Sebastian J, Bino BC, Jayaprakash K, Vijayakumar K, Sujathan P, Adinegara LA. Postgrad Med J; 2008 Apr; 84(990):205-10. PubMed ID: 18424578 [Abstract] [Full Text] [Related]
25. Cystatin C improves the diagnosis and stratification of chronic kidney disease, and the estimation of glomerular filtration rate in diabetes. Rigalleau V, Beauvieux MC, Le Moigne F, Lasseur C, Chauveau P, Raffaitin C, Perlemoine C, Barthe N, Combe C, Gin H. Diabetes Metab; 2008 Nov; 34(5):482-9. PubMed ID: 18703370 [Abstract] [Full Text] [Related]
27. Abnormal renal structural alterations during the development of diabetes mellitus in Otsuka Long-Evans Tokushima Fatty rats. Koike T, Tomoda F, Kinuno H, Inoue H, Takata M. Acta Physiol Scand; 2005 May; 184(1):73-81. PubMed ID: 15847646 [Abstract] [Full Text] [Related]
28. Kidney function and cardiovascular disease in the hypertensive population: the ERIC-HTA study. Redón J, Cea-Calvo L, Lozano JV, Fernández-Pérez C, Navarro J, Bonet A, González-Esteban J, ERIC-HTA 2003 Study Investigators. J Hypertens; 2006 Apr; 24(4):663-9. PubMed ID: 16531794 [Abstract] [Full Text] [Related]
29. Improving care of patients with diabetes and CKD: a pilot study for a cluster-randomized trial. Cortés-Sanabria L, Cabrera-Pivaral CE, Cueto-Manzano AM, Rojas-Campos E, Barragán G, Hernández-Anaya M, Martínez-Ramírez HR. Am J Kidney Dis; 2008 May; 51(5):777-88. PubMed ID: 18436088 [Abstract] [Full Text] [Related]
30. Long-term decline in renal function is linked to initial pulse pressure in the essential hypertensive. Gosse P, Coulon P, Papaioannou G, Litalien J, Lemetayer P. J Hypertens; 2009 Jun; 27(6):1303-8. PubMed ID: 19307982 [Abstract] [Full Text] [Related]
32. Microalbuminuria and the risk for early progressive renal function decline in type 1 diabetes. Perkins BA, Ficociello LH, Ostrander BE, Silva KH, Weinberg J, Warram JH, Krolewski AS. J Am Soc Nephrol; 2007 Apr; 18(4):1353-61. PubMed ID: 17329575 [Abstract] [Full Text] [Related]
35. The advanced glycation end product N(epsilon)-carboxymethyllysine is not a predictor of cardiovascular events and renal outcomes in patients with type 2 diabetic kidney disease and hypertension. Busch M, Franke S, Wolf G, Brandstädt A, Ott U, Gerth J, Hunsicker LG, Stein G, Collaborative Study Group. Am J Kidney Dis; 2006 Oct; 48(4):571-9. PubMed ID: 16997053 [Abstract] [Full Text] [Related]